我们的网站为什么显示成这样?

可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:

|本期目录/Table of Contents|

穿山龙总皂苷对哮喘小鼠气道重塑及MMP-9、TIMP-1表达的影响(PDF)

《云南中医学院学报》[ISSN:1000-2723/CN:53-1048/R]

期数:
2014年06期
页码:
1-4
栏目:
实验研究
出版日期:
2014-12-25

文章信息/Info

Title:
Protective Effect of Con-saponin of Dioscoreae Nipponicae on Asthma-induced Airway Remodeling and Expression of MMP-9 and TIMP-1 in Asthmatic Mice
作者:
胡晶晶1杨珺超2汪潞1江立斌2
1. 浙江中医药大学第一临床医学院,浙江杭州 310053; 2. 浙江中医药大学附属第一医院、浙江省中医院,浙江杭州 310006
Author(s):
HU Jing-jing1 YANG Jun-chao2 WANG Lu1 JIANG Li-bing2
1. The First Clinical Medical College, Zhejiang Chinese Medical University, Hangzhou 310053, China; 2. Zhejiang Provincial Hospital of Traditional Chinese Medicine, Hangzhou 310006, China
关键词:
穿山龙总皂苷 哮喘 气道重塑
Keywords:
Con-saponin of Dioscoreae Nipponicae asthma airway remodeling
分类号:
R285.5
DOI:
-
文献标识码:
A
摘要:
目的研究穿山龙总皂苷对哮喘小鼠气道重塑和MMP-9、TIMP-1蛋白表达的影响,并探讨其中作用机制。方法将60只清洁级BALB/c小鼠随机分为6组(n=10):A组(空白组),B组(哮喘模型组),C组[阳性对照组(醋酸泼尼松组)],D组(低剂量组),E组(中剂量组),F组(高剂量组)。卵白蛋白(OVA)致敏激发小鼠制作哮喘气道重塑模型,在实验第18-55天,空白组、模型组以生理盐水灌胃,阳性对照组给醋酸泼尼松混悬液10 mg/kg,药物组分别给予穿山龙总皂苷20 mg/kg、40 mg/kg、80 mg/kg治疗。用HE染色法观察各组小鼠肺组织病理形态变化;用蛋白免疫印记法(Western Blot)测定各组MMP-9、TIMP-1蛋白表达。结果穿山龙总皂苷能够改善哮喘小鼠气道壁及上皮结构,减少黏膜下及管壁周围炎性细胞浸润;与空白对照组比较,小鼠哮喘模型组MMP-9表达明显升高(P<0.05),TIMP-1表达明显降低(P<0.05);与模型组比较,各治疗组MMP-9表达明显降低(P<0.05),TIMP-1表达明显升高(P<0.05);MMP-9在各穿山龙总皂苷组表达强于阳性对照组,TIMP-1在各穿山龙总皂苷组表达弱于阳性对照组。结论穿山龙总皂苷能够改善哮喘小鼠气道结构,并可通过抑制MMP-9、增加TIMP-1蛋白的表达从而减轻小鼠哮喘气道重塑状态。
Abstract:
Objective To Study the effect of Con-saponin of Dioscoreae Nipponicae(CDN) on expressions of airway remodeling and to investigate the role of matrix metallo proteinase-9(MMP-9 ) and its tissue inhibitor (TIMP-1) in asthmatic mice. Methods Sixty SPF BALB/c mice were randomly divided into six group:normal group, model group, the Prednisone therapy group, low -dose CDN group, medium -dose CDN group, high -dose CDN group. The six groups except normal group were established by ovalbumin(OVA) sensitization.During the 18~55 days in the experiment, the normal and model groups were treated with normal saline, the Prednisone therapy group were treated with 10mg/kg of prednisone. At the same time, CDN groups were respectively treated with 20mg/kg、40mg/kg、80mg/kg of CDN. The pathological change of lung issues structure was studied under light microscopy and the expression of MMP-9 and TIMP-1 in lung tissues was detected by Western blotting. Results The pathological changes in lung tissue of asthmatic mice showed that CDN could improve the structure of the wall of the airway wall and epithelial, and reduce the infiltration of inflammatory cells. Compared with the normal group, The level of MMP-9 was significantly increased and TIMP-1 was significantly decreased in the model group(P<0.05). Compared with the model group, the treatment groups significantly decreased the expression of MMP-9 (P<0.05) and significantly increased the expression of TIMP-1 (P<0.05). The level of MMP-9 in all CDN groups was higher than the prednisone therapy group, and the level of TIMP-1 in all CDN groups lower in the prednisone therapy group. Conclusion CDN can improve the airway structure of asthmatic mice, and through inhibiting the expression of MMP-9 and increasing the expression of TIMP-1 to reduce the mice airway remodeling in asthma status.

参考文献/References

[1] Halwani R,Al-Muhsen S,Hamid Q. Airway remodeling in asthma [J]. Curr Opin Pharmacol,2010,10(3):236-245.
[2] Moore CS,Crocker SJ. An alternate perspective on the roles of TIMPs and MMPs in pathology[J]. Am J Pathol 2012,180(1):12-16.
[3] 中华医学会呼吸病学分会哮喘学组. 支气管哮喘防治指南[J]. 中华结核和呼吸杂志,2008,31(3):177-185.
[4] Usmani OS. Small airways dysfunction in asthma:evaluation and management to improve asthma control[J]. Allergy Asthma Immunol Res,2014,6(5):376-388.
[5] 李淼,尚云晓,魏兵. 布地奈德吸入对哮喘气道重塑大鼠气道平滑肌细胞 MMP-9 及 TIMP-1 表达的影响 [J]. 中国组织化学与细胞化学杂志,2012,21(2):142-145.
[6] 张维溪,戴欢,贺孝良,等. 糖皮质激素调控哮喘大鼠气道重塑中TGF-β_1/Smad信号通路的研究[J]. 中国药理学通报,2009(9):1142-1146.
[7] Wu SM,Li CE,Cai RP,et al . Airway remodeling assessed by high-resolution computed tomography in patients with asthma:relationship to biological markers in induced sputum[J]. Article in Chinese,2012,35(12):892-896.
[8] Ohbayashi H,Shimokata K. Matrix metalloproteinase-9 and airway remodeling in asthma[J]. Curr Drug Targets Inflamm Allergy,2005,4(2):177-181.
[9] Rogers NK,Clements D,Dongre A,et al. Extra-cellular matrix proteins induce matrix metalloproteinase-1(MMP-1)activity and increase airway smooth muscle contraction in asthma[J]. PLoS One,2014,9(2):1-12.
[10] 王成阳,刘向国,彭青和,等. MMPs系统和细胞因子在慢性阻塞性肺疾病模型大鼠中的作用[J]. 免疫学杂志,2013,(12):1024-1028.
[11] 姚丽,刘树民,王加志,等. 穿山龙中薯蓣皂苷元的提取分离及测定方法研究概况[J]. 中华中医药学刊,2008,26(1):164-165.
[12] 丁小林,李卿. 中药穿山龙的研究进展[J]. 重庆中草药研究,2003,48(2):55-57.
[13] 唐丽香. 福建穿山龙抗炎镇痛作用的实验研究[J]. 海峡药学,2000(3):34.
[14] 南景一,王忠,杨玉娟,等. 穿山龙对小鼠免疫功能的影响[J]. 中草药,1998,19(3):22.
[15] 雷励. 穿山龙注射液穴位注射治疗重症支气管哮喘临床观察[J]. 中国中医急症,2005,14(5):219-220.

备注/Memo

备注/Memo:
基金项目: 浙江省教育厅资助项目(20070708);浙江省中医药科技计划项目(2011ZB035);浙江省教育厅科研项目(Y201430732) 收稿日期: 2014 - 10 - 28 作者简介: 胡晶晶(1990-),男,浙江慈溪人,在读硕士研究生,研究方向:中西医结合呼吸病学。 △通信作者:江立斌,E-mail:jkzjuedu@163.com
更新日期/Last Update: 2014-12-20